Word

KAABEV

Status

Dead

Status Code

710

Status Date

Tuesday, November 24, 2020

Serial Number

86040258

Registration Number

4517601

Registration Date

Tuesday, April 22, 2014

Mark Type

4000

Filing Date

Friday, August 16, 2013

Published for Opposition

Tuesday, February 4, 2014

Cancellation Date

Tuesday, November 24, 2020

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

The wording "KAABEV" has no meaning in a foreign language.

Trademark Events

Nov 24, 2020

Cancelled Sec. 8 (6-Yr)

Apr 22, 2019

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jun 23, 2015

Teas Change Of Correspondence Received

Apr 22, 2014

Registered-Principal Register

Feb 4, 2014

Official Gazette Publication Confirmation E-Mailed

Feb 4, 2014

Published For Opposition

Jan 15, 2014

Notification Of Notice Of Publication E-Mailed

Dec 31, 2013

Law Office Publication Review Completed

Dec 30, 2013

Assigned To Lie

Dec 4, 2013

Approved For Pub - Principal Register

Dec 4, 2013

Examiner's Amendment Entered

Dec 4, 2013

Notification Of Examiners Amendment E-Mailed

Dec 4, 2013

Examiners Amendment E-Mailed

Dec 4, 2013

Examiners Amendment -Written

Dec 3, 2013

Assigned To Examiner

Aug 24, 2013

New Application Office Supplied Data Entered In Tram

Aug 20, 2013

New Application Entered In Tram